The Johnson & Johnson recall of its over-the-counter medications continued today. Earlier in the month, a moldy smell in select Tylenol Arthritis caplets was making consumers ill, leading the company to withdraw several of its products from shelves. The medicines now being recalled now includes some batches of regular and extra-strength Tylenol children's Tylenol, eight-hour Tylenol, Tylenol arthritis, Tylenol PM, children's Motrin, Motrin IB, Benadryl Rolaids, Simply Sleep, and St. Joseph's aspirin. Both caplet and geltab varieties of Johnson & Johnson products sold in the United Arab Emirates, Fiji and the U.S. have all been pulled off shelves.
Johnson & Johnson’s McNeil Consumer Healthcare products, who only recalled the Tylenol Arthritis Caplets after numerous cases of vomiting, diarrhea and other side effects has raised eye brows with the lackadaisical pace of the recall.
The Food and Drug Administration believes the problems began in 2008, but they waited for the issues to become publicly recognized to take action. Roughly 70 people are said to have become ill from the product.
The Food and Drug Administration said McNeil knew of the problem in early 2008 but made only a limited investigation.
The agency said about 70 people were either sickened by the odor, or noticed it.
About EQUITIES:
Since 1951, EQUITIES Magazine has been a leading media company providing business editorial content designed to serve the needs of business leaders, professionals, institutional investors and retail investors. We are focused on business and the business of making money, not on lifestyle subjects. We publish original reporting in print and on our website, as well as select content at www.nasdaq.com. For 28 years we have hosted our own branded investor conferences that connect public company CEO’s with our loyal readers in the investment community.
Sign up for a free one-year subscription
